D.E. Shaw & Co’s BioTelemetry, Inc. BEAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-14,265
Closed -$471K 3905
2017
Q3
$471K Sell
14,265
-77,644
-84% -$2.69M ﹤0.01% 2943
2017
Q2
$3.07M Sell
91,909
-36,408
-28% -$1.09M 0.01% 1694
2017
Q1
$3.71M Sell
128,317
-26,938
-17% -$667K 0.01% 1469
2016
Q4
$3.47M Sell
155,255
-15,388
-9% -$301K 0.01% 1570
2016
Q3
$3.17M Sell
170,643
-243,693
-59% -$4.6M 0.01% 1587
2016
Q2
$6.75M Buy
414,336
+10,436
+3% +$154K 0.01% 1106
2016
Q1
$4.72M Buy
403,900
+103,548
+34% +$1.16M 0.01% 1319
2015
Q4
$3.51M Sell
300,352
-36,785
-11% -$465K 0.01% 1689
2015
Q3
$4.13M Sell
337,137
-117,225
-26% -$1.49M 0.01% 1538
2015
Q2
$4.29M Buy
454,362
+34,441
+8% +$319K 0.01% 1587
2015
Q1
$3.72M Buy
419,921
+132,980
+46% +$1.34M 0.01% 1571
2014
Q4
$2.88M Buy
286,941
+51,992
+22% +$446K ﹤0.01% 1966
2014
Q3
$1.58M Sell
234,949
-3,971
-2% -$27.8K ﹤0.01% 2419
2014
Q2
$1.71M Sell
238,920
-152,745
-39% -$1.22M ﹤0.01% 2437
2014
Q1
$3.95M Sell
391,665
-116,685
-23% -$1.07M 0.01% 1764
2013
Q4
$4.04M Buy
508,350
+130,559
+35% +$1.22M 0.01% 1876
2013
Q3
$3.74M Buy
377,791
+308,691
+447% +$2.43M 0.01% 1863
2013
Q2
$408K Buy
+69,100
New +$233K ﹤0.01% 3389

Other funds holding BEAT

D.E. Shaw & Co's BEAT Position: Q4 2017 in Review

D.E. Shaw & Co sold out of BioTelemetry, Inc. (BEAT) in Q4 2017, closing a stake of 14,265 shares — an estimated $471K sold.

D.E. Shaw & Co first reported a position in BEAT in Q2 2013 and held it in 18 quarters. The position peaked at $6.75M in Q2 2016. 192 funds tracked by Wall St. Rank hold BEAT as of Q4 2017.

  • D.E. Shaw & Co reported no remaining BioTelemetry, Inc. position as of Q4 2017 after selling out during the quarter.
  • D.E. Shaw & Co sold 14,265 BioTelemetry, Inc. shares in Q4 2017, an estimated $471K.
  • D.E. Shaw & Co first reported a position in BioTelemetry, Inc. in Q2 2013 and held it in 18 quarters.
  • D.E. Shaw & Co's BioTelemetry, Inc. position peaked at $6.75M in Q2 2016.
  • 192 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q4 2017.

Based on D.E. Shaw & Co's 13F filing for Q4 2017, filed 14 Feb 2018.